Patrick Erickson

Mr. Patrick Erickson

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Analytical Biochemistry
Verified
Journal Article
Closed access
PEPatrick Erickson
Patrick Erickson
THTony Houwayek
Tony Houwayek
ABAlexandra Burr
Alexandra Burr
MTMatthew Teryek
Matthew Teryek
BPBiju Parekkadan
Biju Parekkadan

22 April 2025 in Communications Biology
Verified
Journal Article
Open access
PDF file
VPVaibhav Prakash Pai
Vaibhav Prakash Pai
LPLéo Pio-Lopez
Léo Pio-Lopez
MSMegan M. Sperry
Megan M. Sperry
PEPatrick Erickson
Patrick Erickson
PTParande Tayyebi
Parande Tayyebi
Michael LevinMichael Levin
Michael Levin
Would transcriptomes change if cell collectives acquired a novel morphogenetic and behavioral phenotype in the absence of genomic editing, transgenes, heterologous materials, or drugs? We investigate the effects of morphology and nascent emergent life history on gene expression in the basal (no engineering, no sculpting) form of Xenobots —autonomously motile constructs derived from Xenopus embryo ectodermal cell explants. To investigate gene expression differences between cells in the context of an embryo with those that have been freed from instructive signals and acquired novel lived experiences, we compare transcriptomes of these basal Xenobots with age-matched Xenopus embryos. Basal Xenobots show significantly larger inter-individual gene variability than age-matched embryos, suggesting increased exploration of the transcriptional space. We identify at least 537 (non-epidermal) transcripts uniquely upregulated in these Xenobots. Phylostratigraphy shows a majority of transcriptomic shifts in the basal Xenobots towards evolutionarily ancient transcripts. Pathway analyses indicate transcriptomic shifts in the categories of motility machinery, multicellularity, stress and immune response, metabolism, thanatotranscriptome, and sensory perception of sound and mechanical stimuli. We experimentally confirm that basal Xenobots respond to acoustic stimuli via changes in behavior. Together, these data may have implications for evolution, biomedicine, and synthetic morphoengineering.

Verified
Journal Article
Open access
PDF file
ADAneesha Doshi
Aneesha Doshi
PEPatrick Erickson
Patrick Erickson
MTMatthew Teryek
Matthew Teryek
BPBiju Parekkadan
Biju Parekkadan
Mesenchymal stromal cells (MSCs) are a candidate for cell immunotherapy due to potent immunomodulatory activity found in their secretome. Though studies on their secreted substances have been reported, the time dynamics of MSC potency remain unclear. Herein, we report on the dynamics of MSC secretome potency in an ex vivo hollow fiber bioreactor using a continuous perfusion cell culture system that fractionated MSC-secreted factors over time. Time-resolved fractions of MSC-conditioned media were evaluated for potency by incubation with activated immune cells. Three studies were designed to characterize MSC potency under: (1) basal conditions, (2) in situ activation, and (3) pre-licensing. Results indicate that the MSC secretome is most potent in suppressing lymphocyte proliferation during the first 24 h and is further stabilized when MSCs are prelicensed with a cocktail of pro-inflammatory cytokines, IFNγ, TNFα, and IL-1β. The evaluation of temporal cell potency using this integrated bioreactor system can be useful in informing strategies to maximize MSC potency, minimize side effects, and allow greater control for the duration of ex vivo administration approaches.

24 July 2020 in FEBS Open Bio
Verified
Journal Article
Open access
PDF file
ATAlfred G. Tamayo
Alfred G. Tamayo
SSSyukri Shukor
Syukri Shukor
ABAlexandra Burr
Alexandra Burr
PEPatrick Erickson
Patrick Erickson
BPBiju Parekkadan
Biju Parekkadan
Transcriptional dynamics of cancer cells govern cell fate decisions and are therapeutically actionable drug targets. In this study, we engineered a circulating cancer cell line that secretes a luciferase reporter to capture constitutive and circadian clock‐driven transcription dynamics over the course of a day. Engineered human leukemic T cells (Jurkat) were observed to rhythmically secrete luciferase in a continuous flow cell culture system. When transplanted in vivo, engineered leukemic cells caused circadian plasma luciferase activity and had expected pathological signs of leukemic disease. This technique is rapid and noninvasive, requiring only a few microliters of media or blood, and can aid in investigating relationships between in vivo cancer cell signaling and behavior, such as diet or sleep.

9 July 2025 in Bioelectricity
Verified
Journal Article
Open access
SKStefania E. Kapsetaki
Stefania E. Kapsetaki
APAngelina Pimkina
Angelina Pimkina
PMPatrick McMillen
Patrick McMillen
PTParande Tayyebi
Parande Tayyebi
PEPatrick Erickson
Patrick Erickson
Michael LevinMichael Levin
Michael Levin
Introduction: Bioelectric properties of cells are an important aspect of development, regeneration, and cancer. Because of their relevance to the establishment and maintenance of tissue form and function, bioelectric patterns have been hypothesized to have a role in aging. However, no data on bioelectric patterns of the whole body of young and old individuals have been available. Methods: We observed and quantified the bioelectrics of whole-body immortal (growing at 22°C) and aging mortal (growing at 10°C) cold-sensitive Hydra oligactis . Results: We found that the membrane-voltage-sensitive dyes FluoVolt and VF2.1.Cl can be used to reveal large-scale patterns of cellular membrane resting voltage potentials in hydra. The consensus whole-body bioelectric atlas of immortal hydra shows a consistently depolarized foot and occasionally depolarized tentacles. Immortal hydra are, on average, more depolarized and exhibit less sharply defined bioelectric patterns than old mortal hydra. Immortal hydra have a sharper foot:central body ratio than old mortal hydra. Conclusions: These data establish hydra as the first model system in which whole-body bioelectric imaging can be performed; the different bioelectric patterns of immortal versus old mortal hydra are consistent with a bioelectric component to the aging process and suggest a roadmap for using this model organism in antiaging therapeutic screens involving electroceuticals.

1 March 2025 in Bioelectricity
Verified
Journal Article
Closed access
JMJuanita Mathews
Juanita Mathews
PEPatrick Erickson
Patrick Erickson
FKFranz Kuchling
Franz Kuchling
NJNavneet Jawanda
Navneet Jawanda
LPLéo Pio-Lopez
Léo Pio-Lopez
Michael LevinMichael Levin
Michael Levin
The Office of Cancer Complementary and Alternative Medicine, part of the Division of Cancer Treatment and Diagnosis under the National Cancer Institute (NCI), supports research in diverse areas of cancer therapeutics such as microbial therapies, herbal remedies, and mind–body practices. Recently they have become especially interested in the emerging role of bioelectricity in cancer biology and organized a virtual meeting with some of the top scientists in the field. In this report, we overview this first-of-its-kind Naional Institute of Health (NIH)-sponsored meeting, which featured talks from 14 researchers exploring the role of bioelectricity in cancer biology. The talks covered a wide range of topics, including excellent background information on how cell collectives change their bioelectrical coupling and set points during cancer formation, new tools for reading and writing bioelectrical signatures in cells and whole organisms, how ion channels that are involved in setting those signatures affect canonical pathways in development and tumor growth, and the methods for modeling bioelectrical interactions and information transfer in cell collectives. Especially exciting were the translational technologies that were highlighted, including new diagnostics, metastasis inhibition therapies, and more efficient detection of surgical margins. The meeting concluded with funding opportunities available from the NCI Division of Cancer Biology, Innovative Molecular Analysis Technologies Program, and the Small Business Innovation Research Development Center.